The Lag3 Relatli Biosimilar (HDBS0060) is a cutting-edge product designed for researchers studying Lag3, a cell surface protein known for its role in immune regulation. This biosimilar antibody, derived from a proprietary process, is optimized for use in various applications, particularly in Western blot analysis. It specifically targets the Lag3 protein, enabling researchers to detect and analyze its expression in different cell types.Lag3, also referred to as lymphocyte-activation gene 3, is a key player in immune response modulation, exerting inhibitory effects on immune cells.
Its involvement in regulating T cell function and maintaining immune tolerance makes it a promising target for studying immune-related diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions. By understanding the mechanisms through which Lag3 operates, researchers can potentially develop novel therapies that modulate immune responses for therapeutic benefit.
Product Name:
Relatlimab (Anti-LAG3) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0060
Target:
LAG3
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
LAG-3,CD223
Description:
Anti-LAG3 (relatlimab biosimilar)mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
